Transgene SA

EPA:TNG.PA

0.87 (EUR) • At close November 8, 2024
Bedrijfsnaam Transgene SA
Symbool TNG.PA
Munteenheid EUR
Prijs 0.871
Beurswaarde 122,769,261
Dividendpercentage 0%
52-weken bereik 0.834 - 1.528
Industrie Biotechnology
Sector Healthcare
CEO Dr. Alessandro Riva M.D.
Website https://www.transgene.fr

An error occurred while fetching data.

Over Transgene SA

Transgene SA, a biotechnology company, focuses on designing and developing therapeutic vaccines and oncolytic viruses for the treatment of cancer and infectious diseases. It is involved in developing TG4050, a therapeutic vaccine that is in phase I clinical trial for the treatment of ovarian cancer, and human papilloma virus (HPV)-negative

Vergelijkbare Aandelen

Eurobio Scientific Société anonyme logo

Eurobio Scientific Société anonyme

ALERS.PA

25.75 EUR

Laboratorio Reig Jofre, S.A. logo

Laboratorio Reig Jofre, S.A.

RJF.MC

2.92 EUR

Carmat SA logo

Carmat SA

ALCAR.PA

1.354 EUR

Innate Pharma S.A. logo

Innate Pharma S.A.

IPH.PA

1.61 EUR

Prim, S.A. logo

Prim, S.A.

PRM.MC

9.74 EUR

Bastide Le Confort Médical SA logo

Bastide Le Confort Médical SA

BLC.PA

17.84 EUR

Biosynex SA logo

Biosynex SA

ALBIO.PA

2.76 EUR

Malin Corporation plc logo

Malin Corporation plc

MLC.IR

5.8 EUR

ABIVAX Société Anonyme logo

ABIVAX Société Anonyme

ABVX.PA

9.61 EUR

Median Technologies SA logo

Median Technologies SA

ALMDT.PA

4.105 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)